Mylan Pharmaceuticals Inc. recalls Mirtazapine Tablets, USP 45 mg, a) 30 count, b) 100 count and c) 500 count bottles, Rx only, Mylan Pharmaceuticals Inc.,
Recalled March 15, 2017 · FDA recall D-0492-2017 · Mylan Pharmaceuticals
Hazard
Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablet in bottle · FDA Class II
Units
37,445 bottles
Sold at
Nationwide
Description
Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablet in bottle
Product
Mirtazapine Tablets, USP 45 mg, a) 30 count, b) 100 count and c) 500 count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV
Manufacturer(s)
Mylan Pharmaceuticals Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →